For the year ending 2025-12-31, ATOS has $47,608K in assets. $8,255K in debts. $41,299K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 41,299 | |||
| Restricted cash | 110 | |||
| Prepaid materials | 3,081 | |||
| Prepaid expenses and other current assets | 1,128 | |||
| Total current assets | 45,618 | |||
| Other assets | 1,990 | |||
| Total assets | 47,608 | |||
| Accounts payable | 4,293 | |||
| Accrued expenses | 1,307 | |||
| Payroll liabilities | 1,558 | |||
| Other current liabilities | 1,097 | |||
| Total current liabilities | 8,255 | |||
| Total liabilities | 8,255 | |||
| Common stock - 0.18 par value 350,000,000 shares authorized 8,611,361 and 8,611,266 shares issued and outstanding as of december 31, 2025 and 2024 | 1,550 | |||
| Additional paid-in capital | 285,840 | |||
| Treasury stock, at cost 88,003 shares of common stock at december 31, 2025 and 2024 respectively | 1,475 | |||
| Accumulated deficit | -246,562 | |||
| Total stockholders' equity | 39,353 | |||
| Total liabilities and stockholders' equity | 47,608 | |||
ATOSSA THERAPEUTICS, INC. (ATOS)
ATOSSA THERAPEUTICS, INC. (ATOS)